이상반응 보고
| VAERS ID | 931224 |
|---|---|
| 성별 | 여성 |
| 나이 | 39세 |
| 주 코드 | TX |
| 제약회사 | PFIZER\BIONTECH |
| 로트 번호 | EJ1686 |
| 예방접종 횟수 | 2 |
| 접종일 | 2021-01-04 |
| 발병일 | 2021-01-05 |
| 상태 | 입원 후유증 |
증상
- 피로(Fatigue)
- 두통(Headache)
- 무력증(Asthenia)
- 구토(Vomiting)
- 졸음(Somnolence)
- 졸도(Syncope)
- 근육 약화(Muscular weakness)
- 전체 혈구 수 정상(Full blood count normal)
- 대사 기능 검사 정상(Metabolic function test normal)
- 보행 장애(Gait disturbance)
- 컴퓨터 단층 촬영 머리 정상(Computerised tomogram head normal)
- 언어 장애(Speech disorder)
- 컴퓨터 단층 촬영 헤드(Computerised tomogram head)
- 요추 천자 정상(Lumbar puncture normal)
- 혈액 갑상선 자극 호르몬 정상(Blood thyroid stimulating hormone normal)
- 척추 엑스레이 정상(Spinal X-ray normal)
- 비타민 B12 감소(Vitamin B12 decreased)
- CSF 단백질 정상(CSF protein normal)
- CSF 세포 수 정상(CSF cell count normal)
- CSF 문화(CSF culture)
- Hypoflexia(Hyporeflexia)
이환 중 질병
NONE
지병
Hypothyroidism, ADHD
기타 의료
Levothyroxine 200 mcg, Vyvanse 60 mg
이전 예방접종
알레르기
SHELLFISH, CECLOR
임상 검사
1/6/21 Normal BMP, CBC, normal TSH, low B12 Lumbar Puncture: normal cell count and protein, culture pending Cervical Spine xray: Normal CT brain (noncontrast): normal
증상 상세
Pt experienced extreme fatigue and sleepiness the day following her second vaccination for Covid 19 and was found by her family after collapsing on 1/6/21 at 05:30.
Upon arousal, she experienced headache, vomiting, weakness, difficulty speaking and difficulty walking with lower extremity weakness.
She was taken to urgent care and subsequently admitted for evaluation at hospital and found to have a normal chemistry, blood count, normal lumbar puncture and normal imaging of her neck and brain.
Discharge summary notes 3/5 strength and hyporeflexia throughout.
Pt had televisit consult with psychiatry and neurology.
She is subsequently to be discharged to a Facility without explanation for her sudden onset of progressive lower extremity and vocal weakness.
She is noted to have a history of shellfish allergy.
She experienced mild symptoms after the first vaccination, but no neurologic or vascular symptoms at that time.